Currently, an ongoing international multicenter retrospective study initiated by the International PSC Study Group (IPSCSG) is investigating the effect on ALP and PSC-related clinical events of anti-TNF-α therapy used for IBD in PSC patients. The gene discussed is TNF; the disease is inflammatory bowel disease.